psoriasis
Mindera Health Closes $14M Convertible Note Financing
The company said it will use the proceeds of the transaction to roll out a test for determining a patient's response to psoriasis treatments.
The firm is hoping that growing real-world evidence for DecisionDx-Melanoma will support better clinical recognition as it continues to expand its menu.
Theradiag Gets CE Mark for Cosentyx Response Kit
Cosentyx is a human monoclonal antibody marketed by Novartis that is used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Theradiag Providing Kits to Biogen for Autoimmune Biosimilar Monitoring
Biogen will now be able to supply Lisa Tracker monitoring kits in the competitive tenders in which it participates in France and other parts of Europe.